KR102502111B1 - Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability - Google Patents
Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability Download PDFInfo
- Publication number
- KR102502111B1 KR102502111B1 KR1020220112268A KR20220112268A KR102502111B1 KR 102502111 B1 KR102502111 B1 KR 102502111B1 KR 1020220112268 A KR1020220112268 A KR 1020220112268A KR 20220112268 A KR20220112268 A KR 20220112268A KR 102502111 B1 KR102502111 B1 KR 102502111B1
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- composition
- idcc
- lactococcus lactis
- functional food
- Prior art date
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 229930003761 Vitamin B9 Natural products 0.000 title claims abstract description 27
- 235000019159 vitamin B9 Nutrition 0.000 title claims abstract description 27
- 239000011727 vitamin B9 Substances 0.000 title claims abstract description 27
- 235000014897 Streptococcus lactis Nutrition 0.000 title claims abstract description 21
- OGQHCUYSWDOIMP-UHFFFAOYSA-N 7-(diethylamino)-n-[2-[(2-iodoacetyl)amino]ethyl]-2-oxochromene-3-carboxamide Chemical compound C1=C(C(=O)NCCNC(=O)CI)C(=O)OC2=CC(N(CC)CC)=CC=C21 OGQHCUYSWDOIMP-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 235000013376 functional food Nutrition 0.000 title claims abstract description 11
- 241000194035 Lactococcus lactis Species 0.000 title claims abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 235000013305 food Nutrition 0.000 claims description 19
- 235000013351 cheese Nutrition 0.000 claims description 4
- 244000057717 Streptococcus lactis Species 0.000 description 17
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 9
- 239000006041 probiotic Substances 0.000 description 8
- 235000018291 probiotics Nutrition 0.000 description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 6
- 239000011724 folic acid Substances 0.000 description 6
- 229960000304 folic acid Drugs 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000015203 fruit juice Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000000276 neural tube Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000019666 ageusia Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- AKRQHOWXVSDJEF-UHFFFAOYSA-N heptane-1-sulfonic acid Chemical compound CCCCCCCS(O)(=O)=O AKRQHOWXVSDJEF-UHFFFAOYSA-N 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940068088 vitamin k 1 Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7058—Vitamin B9
-
- A23Y2240/41—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 비타민 B9 생성능이 우수한 락토코커스 락티스 IDCC 2301을 포함하는 조성물 및 건강기능식품에 관한 것이다. The present invention relates to a composition and health functional food containing Lactococcus lactis IDCC 2301 having excellent vitamin B9 production ability.
비타민은 체내 신진대사에 필수적인 미량의 유기물질로, 신체의 발육, 일상 활동 및 건강 유지를 위한 영양소이다. 비타민은 크게 지용성 비타민과 수용성 비타민으로 분류가 된다. 지용성 비타민은 체내 지방조직 또는 간에 축적되어 장시간 저장이 가능한 반면, 수용성 비타민은 체내에 저장되지 않고 소변을 통해 배출되기 때문에 꾸준한 섭취가 필요하다. Vitamins are trace amounts of organic substances essential for metabolism in the body and are nutrients for the body's development, daily activities, and maintenance of health. Vitamins are broadly classified into fat-soluble vitamins and water-soluble vitamins. Fat-soluble vitamins accumulate in the body's fat tissue or liver and can be stored for a long time, whereas water-soluble vitamins are not stored in the body and are excreted through urine, so a steady intake is necessary.
비타민 B9(엽산, folic acid)은 세포 생성에 관여하는 수용성 비타민으로, 아미노산, 핵산 및 적혈구 합성에 필수적인 영양소이다. 특히, 엽산이 태아의 신경관 발달에 중요한 역할을 하기 때문에 임산부에게 권장되는 비타민이다. 또한 엽산은 관상동맥 질환의 위험인자인 혈중 호모시스테인의 수치를 낮추어 동맥경화와 심근경색 등과 같은 질환을 예방 및 개선하는데 도움을 준다. 이 외에도, 피부 노화, 치매, 우울증, 고혈압 등의 질환에 도움을 준다고 알려져 있다. Vitamin B9 (folic acid) is a water-soluble vitamin involved in cell production and is an essential nutrient for the synthesis of amino acids, nucleic acids and red blood cells. In particular, folic acid is recommended for pregnant women because it plays an important role in the development of the neural tube of the fetus. In addition, folic acid helps prevent and improve diseases such as arteriosclerosis and myocardial infarction by lowering the level of homocysteine in the blood, a risk factor for coronary artery disease. In addition to this, it is known to help with diseases such as skin aging, dementia, depression, and high blood pressure.
반면, 엽산의 결핍 시 빈혈이 나타나며, 피로, 숨가쁨, 현기증 등의 증세를 수반한다. 결핍이 심할 경우, 미각 감소, 체중 감소, 위장장애, 우울증 등이 나타날 수 있다. 특히, 임산부에게 엽산이 결핍되면 태아의 신경관 형성에 장애가 생겨 신경관 결손, 선천성 척수 또는 뇌 장애가 있는 기형아를 출산할 위험이 증가된다. 이에 따라, 식품 또는 영양제를 통해 엽산을 꾸준히 복용해주어야 한다. On the other hand, when folic acid is deficient, anemia appears, accompanied by symptoms such as fatigue, shortness of breath, and dizziness. If the deficiency is severe, loss of taste, weight loss, gastrointestinal disorders, and depression may occur. In particular, when a pregnant woman is deficient in folic acid, the neural tube formation of the fetus is impaired, increasing the risk of giving birth to a deformed child with a neural tube defect or congenital spinal cord or brain disorder. Accordingly, it is necessary to take folic acid steadily through food or nutritional supplements.
본 발명은 비타민 B9 생성능이 우수한 락토코커스 락티스 IDCC 2301을 포함하는 조성물 및 건강기능식품을 제공하는 것을 목적으로 한다. An object of the present invention is to provide a composition and health functional food containing Lactococcus lactis IDCC 2301 having an excellent ability to produce vitamin B9.
본 발명의 목적은 비타민 B9 생성 기능을 가지는 조성물에 있어서, 락토코커스 락티스 IDCC 2301[기탁번호: ATCC BAA-2834]를 포함하는 것에 의해 달성된다.The object of the present invention is achieved by including Lactococcus lactis IDCC 2301 [Accession No.: ATCC BAA-2834] in a composition having a vitamin B9 producing function.
상기 락토코커스 락티스 IDCC 2301는 홈메이드 치즈로부터 분리된 것일 수 있다.The Lactococcus lactis IDCC 2301 may be isolated from homemade cheese.
상기 본 발명의 목적은 상기 조성물을 0.1 내지 50중량% 포함하는 비타민 B9 생성 기능을 가지는 식품에 의해 달성될 수 있다.The object of the present invention can be achieved by a food having a vitamin B9 generating function containing 0.1 to 50% by weight of the composition.
상기 본 발명의 목적은 상기 조성물을 0.1 내지 50중량% 포함하는 비타민 B9 생성 기능을 가지는 건강기능식품에 의해 달성될 수 있다.The object of the present invention can be achieved by a health functional food having a function of producing vitamin B9 containing 0.1 to 50% by weight of the composition.
본 발명에 따르면 비타민 B9 생성능이 우수한 락토코커스 락티스 IDCC 2301을 포함하는 조성물 및 건강기능식품이 제공된다. According to the present invention, a composition and health functional food containing Lactococcus lactis IDCC 2301 having excellent vitamin B9 producing ability are provided.
도 1은 표준물질인 비타민 B9의 검량선을 보여주는 그래프이며,
도 2는 유산균 종류에 따른 비타민 B9 생산량을 나타낸 것이다.1 is a graph showing a calibration curve of vitamin B9, which is a standard substance;
Figure 2 shows the production of vitamin B9 according to the type of lactic acid bacteria.
이하 도면을 참조하여 본 발명을 더욱 상세히 설명한다.The present invention will be described in more detail with reference to the following drawings.
첨부된 도면은 본 발명의 기술적 사상을 더욱 구체적으로 설명하기 위하여 도시한 일 예에 불과하므로 본 발명의 사상이 첨부된 도면에 한정되는 것은 아니다. 또한 첨부된 도면은 각 구성요소 간의 관계를 설명하기 위해 크기와 간격 등이 실제와 달리 과장되어 있을 수 있다.Since the accompanying drawings are only examples shown to explain the technical spirit of the present invention in more detail, the spirit of the present invention is not limited to the accompanying drawings. In addition, in the accompanying drawings, sizes and intervals may be exaggerated unlike actual ones in order to explain the relationship between each component.
본 발명은 유산균을 포함하는 비타민 B9 생성능을 가진 조성물에 관한 것이다.The present invention relates to a composition containing lactic acid bacteria and capable of producing vitamin B9.
본 발명의 유산균은 락토코커스 락티스 IDCC 2301[기탁번호: ATCC BAA-2834]를 포함한다.The lactic acid bacteria of the present invention include Lactococcus lactis IDCC 2301 [accession number: ATCC BAA-2834].
조성물에서 락토코커스 락티스 IDCC 2301은 1중량% 내지 100중량%, 10중량% 내지 90중량% 또는 1중량% 내지 10중량%일 수 있다.Lactococcus lactis IDCC 2301 in the composition may be 1% to 100%, 10% to 90% or 1% to 10% by weight.
본 발명은 비타민 B9 생성능이 있는 프로바이오틱스를 포함하는 식품 조성물에 관한 것으로, 락토코커스 락티스 IDCC 2301[기탁번호: ATCC BAA-2834]을 포함한다.The present invention relates to a food composition containing probiotics capable of producing vitamin B9, including Lactococcus lactis IDCC 2301 [Accession No.: ATCC BAA-2834].
락토코커스 락티스 IDCC 2301은 홈메이드 치즈로부터 분리되었으며, 식품 조성물 내지 건강기능식품 조성물은 락토코커스 락티스 IDCC 2301 생균을 0.1억 내지 1000억 또는 1억 내지 100억 CFU/g을 포함할 수 있다.Lactococcus lactis IDCC 2301 was isolated from homemade cheese, and the food composition or health functional food composition may contain 0.1 billion to 100 billion or 100 million to 10 billion CFU/g of live Lactococcus lactis IDCC 2301 cells.
본 발명은 비타민 B9 생성능이 있는 프로바이오틱스를 포함하는 건강기능식품에 관한 것으로, 락토코커스 락티스 IDCC 2301[기탁번호: ATCC BAA-2834]을 유효성분으로 포함한다.The present invention relates to a health functional food containing probiotics capable of producing vitamin B9, and contains Lactococcus lactis IDCC 2301 [accession number: ATCC BAA-2834] as an active ingredient.
본 발명의 조성물은 락토코커스 락티스 IDCC 2301외의 다른 유산균을 포함할 수 있다. The composition of the present invention may contain other lactic acid bacteria other than Lactococcus lactis IDCC 2301.
본 발명의 식품 조성물은 기능성 식품(functional food), 영양 보조제(nutritional supplement), 건강식품(health food) 및 식품 첨가제(food additives) 등의 모든 형태의 식품에 대한 조성물을 포함한다. 상기 유형의 식품 조성물은 당업계에 공지된 통상적인 방법에 따라 다양한 형태로 제조할 수 있다. 예를 들면, 건강식품으로는 유산균이 함유된 껌, 비타민 복합체, 차, 주스 및 드링크 형태로 제조할 수 있으며, 락토코커스 락티스 IDCC 2301을 유효성분으로 하는 식품 조성물을 과립화, 캡슐화 또는 분말화하여 섭취할 수 있다. The food composition of the present invention includes compositions for all types of food, such as functional food, nutritional supplements, health food, and food additives. Food compositions of this type can be prepared in various forms according to conventional methods known in the art. For example, health food can be prepared in the form of gum, vitamin complex, tea, juice and drink containing lactic acid bacteria, and a food composition containing Lactococcus lactis IDCC 2301 as an active ingredient can be granulated, encapsulated or powdered can be ingested.
본 발명의 기능성 식품 조성물은 식품 제조 시에 통상적으로 첨가되는 성분을 포함할 수 있으며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함할 수 있다. 예컨대, 드링크제로 제조되는 경우에는 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.The functional food composition of the present invention may include components commonly added during food preparation, and may include, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, when prepared as a drink, citric acid, high fructose corn syrup, sugar, glucose, acetic acid, malic acid, fruit juice, jujube extract, licorice extract, and the like may be further included.
식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 천연 과일쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 추출물을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다.Food compositions include various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, organic acids, It may contain a protective colloidal thickener, a pH adjusting agent, a stabilizer, a preservative, glycerin, alcohol, a carbonating agent used in carbonated beverages, and the like. In addition, it may contain extracts for the production of natural fruit juice, fruit juice beverages and vegetable beverages. These components may be used independently or in combination.
다른 예로, 식품 조성물의 제형은 산제, 과립제, 환, 정제, 캡슐제의 형태뿐만 아니라 일반 식품 또는 음료의 형태 어느 것이나 가능하다.As another example, the formulation of the food composition may be in the form of powders, granules, pills, tablets, capsules, as well as general food or beverage forms.
식품의 종류에는 특별히 제한은 없고, 식품의 예로는 육류, 소세지, 빵, 쵸콜렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함할 수 있다.The type of food is not particularly limited, and examples of food include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea, There are drinks, alcoholic beverages, vitamin complexes, and the like, and may include all foods in a conventional sense.
일반적으로, 식품 또는 음료의 제조시에 락토코커스 락티스 IDCC 2301의 사용량은 0.1 내지 50중량%, 0.1 내지 20중량% 또는 0.1 내지 10중량% 포함될 수 있다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있다.In general, when preparing food or beverage, the amount of Lactococcus lactis IDCC 2301 used may be 0.1 to 50% by weight, 0.1 to 20% by weight, or 0.1 to 10% by weight. However, in the case of long-term intake for the purpose of health and hygiene or health control, the amount may be less than the above range.
일 구체예에 따른 식품 조성물 중 음료는 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가성분으로 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜일 수 있다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. Among the food compositions according to one embodiment, the beverage may contain various flavoring agents or natural carbohydrates as additional ingredients, like conventional beverages. The aforementioned natural carbohydrates may be monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as thaumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used.
상기 외에 일 구체예에 따른 식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제를 함유할 수 있다. 그 밖에 본 발명의 식품 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다.In addition to the above, the food composition according to one embodiment includes various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin , alcohol, carbonation agents used in carbonated beverages. In addition, the food composition of the present invention may contain fruit flesh for preparing natural fruit juice, fruit juice beverages and vegetable beverages. These components may be used independently or in combination.
이하 실험예를 통해 본 발명을 상세히 설명한다.The present invention will be described in detail through experimental examples below.
[실시예 1] 프로바이오틱스 섭취를 가상한 장모사배지에서 프로바이오틱스 배양 [Example 1] Cultivation of probiotics in long-haired medium simulating intake of probiotics
프로바이오틱스 배양을 위해 표 1에서 제시한 성분이 함유된 장모사배지(GMM; Gut microbiota medium)를 제조한 뒤 121℃, 15분 동안 멸균하였다. 그 후, 플레이트에 배양된 프로바이오틱스 단일 콜로니를 장모사 액체배지에 1일 동안 혐기적으로 37℃ 조건에서 배양한 후 배양액을 4℃, 6,000 rpm 조건에서 원심분리하여 상등액을 회수하였고, 농축기를 사용하여 10배 농축시켰다. 마지막으로, 0.45 ㎛ 크기의 필터를 사용하여 상등액을 여과한 뒤 분석시료를 준비하였다. For probiotics culture, long hair medium (GMM; Gut microbiota medium) containing the components shown in Table 1 was prepared and then sterilized at 121 ° C. for 15 minutes. Thereafter, the probiotics single colony cultured on the plate was anaerobically cultured in a long-haired liquid medium at 37 ° C for 1 day, and then the culture medium was centrifuged at 4 ° C and 6,000 rpm to recover the supernatant, using a concentrator concentrated 10 times. Finally, the supernatant was filtered using a filter having a size of 0.45 μm, and a sample for analysis was prepared.
[실시예 2] 비타민 B9 정량분석[Example 2] Quantitative analysis of vitamin B9
준비된 시료는 액체 크로마토그래피(Nanospace SI-2 3023, SHISEIDO, Tokyo, Japan)를 사용하여 분석하였다. 물질의 분리와 정량을 위해 CAPCELL PAK UG 120 S5 column (4.6 mm id x 250 mm)을 사용하였고, 이동상은 PIC reagent 10 ml + 3th D.W 500 ml혼합액을 이동상 A, PIC reagent 10 ml + 60% Methanol 500 ml 혼합액을 이동상 B로 사용하였다. PIC reagent는 1-Heptanesulfonic acid 1 g + D.W 10 ml + Acetic acid 10 ml를 혼합하여 제조하였으며, 이동상은 0.5 ml/min의 유속으로 흘려주었다. 컬럼 온도는 40℃로 유지되었고, 20 ㎕의 시료를 주입하여 270 nm 파장의 UV 검출기를 이용하여 비타민 B9의 생성여부를 확인하였다. The prepared samples were analyzed using liquid chromatography (Nanospace SI-2 3023, SHISEIDO, Tokyo, Japan). A CAPCELL PAK UG 120 S5 column (4.6 mm id x 250 mm) was used for separation and quantification of substances, and the mobile phase was PIC reagent 10 ml + 3th D.W 500 ml mixture, mobile phase A, PIC reagent 10 ml + 60% Methanol 500 ml mixture was used as mobile phase B. The PIC reagent was prepared by mixing 1 g of 1-Heptanesulfonic acid + 10 ml of D.W + 10 ml of Acetic acid, and the mobile phase was flowed at a flow rate of 0.5 ml/min. The column temperature was maintained at 40° C., and 20 μl of the sample was injected to confirm the production of vitamin B9 using a UV detector with a wavelength of 270 nm.
비타민 B9의 표준물질 농도는 1mg/ml로 준비하였으며, 도 1에서 나타난 바와 같이 검량선의 신뢰도는 99.9% (R2=0.9999)이상임을 확인하였다. 이를 토대로 프로바이오틱스 상등액 내의 비타민 B9 생산량을 정량하여 표 2에 나타내었으며, 생물자원센터에서 락토코커스 락티스 종에 속하는 여러 균주를 구매하여 비타민 B9 생성능을 비교하였다. 또한 장모사배지에서 비타민 B9는 검출되지 않았다.The standard concentration of vitamin B9 was prepared at 1 mg/ml, and as shown in FIG. 1, it was confirmed that the reliability of the calibration curve was 99.9% (R2=0.9999) or higher. Based on this, the vitamin B9 production in the probiotics supernatant was quantified and shown in Table 2, and several strains belonging to the Lactococcus lactis species were purchased from the Biological Resources Center and their vitamin B9 producing abilities were compared. In addition, vitamin B9 was not detected in the long-haired medium.
장모사배지에서 총 14종의 프로바이오틱스를 배양한 결과, 락토코커스 락티스 IDCC 2301에서 비타민 B9 생산능이 가장 우수하였으며, 락토코커스 락티스 KCTC 5종과 비교했을 때도 비타민 B9 생성량이 상대적으로 많은 것을 확인하였다. As a result of culturing a total of 14 types of probiotics in the long-haired medium, Lactococcus lactis IDCC 2301 showed the best vitamin B9 production capacity, and compared to 5 types of Lactococcus lactis KCTC, it was confirmed that the amount of vitamin B9 production was relatively high. .
Claims (4)
비타민 B9 생성능을 가지는 락토코커스 락티스 IDCC 2301[기탁번호: ATCC BAA-2834]를 포함하는 조성물.In the composition having a vitamin B9 producing function,
A composition comprising Lactococcus lactis IDCC 2301 [Accession Number: ATCC BAA-2834] having vitamin B9 producing ability.
상기 락토코커스 락티스 IDCC 2301는 홈메이드 치즈로부터 분리된 조성물.According to claim 1,
The Lactococcus lactis IDCC 2301 composition isolated from homemade cheese.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220112268A KR102502111B1 (en) | 2022-09-05 | 2022-09-05 | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220112268A KR102502111B1 (en) | 2022-09-05 | 2022-09-05 | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102502111B1 true KR102502111B1 (en) | 2023-02-23 |
Family
ID=85329919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220112268A KR102502111B1 (en) | 2022-09-05 | 2022-09-05 | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102502111B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090094235A (en) | 2006-10-04 | 2009-09-04 | 꽁빠니 자베 다노느 | Culture method for favorising the production of k2 vitamin by lactic bacteria and applications thereof in the preparation of food products |
-
2022
- 2022-09-05 KR KR1020220112268A patent/KR102502111B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090094235A (en) | 2006-10-04 | 2009-09-04 | 꽁빠니 자베 다노느 | Culture method for favorising the production of k2 vitamin by lactic bacteria and applications thereof in the preparation of food products |
Non-Patent Citations (6)
Title |
---|
APPLIED FOOD BIOTECHNOLOGY, 2018, 5 (2):107-120. * |
Food Sci Nutr. 2021 Nov 17,10(1):67-74. * |
Food Science and Technology. 2011, 44(9):1859-1864. * |
Food Technol. Biotechnol. 2010, 48(2):243-250. * |
J Appl Biotechnol Rep. 2019 Dec, 6(4):129-136. * |
J Food Sci Technol. 2015 Jun; 52(6): 3513-3519. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
JP7002159B2 (en) | Method for Producing Rare Sugar-Containing Composition and Rare Sugar-Containing Composition | |
EP3158997A1 (en) | Composition with high content of cyclic dipeptide | |
KR102214532B1 (en) | health food composition using pomegranate fermented by lactic acid bacteria and manufacturing method thereof | |
CN101838671B (en) | Method for producing material containing gamma-aminobutyric acid in high content | |
KR102390927B1 (en) | Composition for curing hangover comprising lactobacillus reuteri IDCC 3701 | |
KR102394733B1 (en) | Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria | |
KR102502111B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability | |
KR102423025B1 (en) | Food composition and health functional food containing Lactobacillus rhamnosus IDCC 3201 with proteolytic ability | |
KR20180042936A (en) | a composition comprising the mycelium culture medium from Schizophyllum commune as an active ingredient for preventing or treating liver disease and alleviating hangover | |
JP2009062301A (en) | Essence of morinda citrifolia l. and use thereof | |
KR102502112B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin C production ability | |
KR102502721B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B6 production ability | |
KR102465396B1 (en) | Composition for producing GABA comprising Lactobacillus johnsonii IDCC 9203 and having improved capacity for producing GABA | |
KR102536236B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B1 production ability | |
KR102502109B1 (en) | Composition and health functional food containing Lacticaseibacillus rhamnosus IDCC 3201 having vitamin B1 production ability | |
KR102549523B1 (en) | Food composition and health functional food containing Streptococcus thermophilus IDCC 2201 with vitamin B2 production ability | |
KR102502110B1 (en) | Composition and health functional food containing Bacillus coagulans IDCC 1201 having vitamin B3 production ability | |
JP6841444B2 (en) | Immunostimulant | |
KR102523776B1 (en) | Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability | |
US20100197611A1 (en) | Alternative agent with vitamin d-like activity and an improving agent for intestinal function | |
CN114680339A (en) | Nutritional supplement for improving muscle attenuation and delaying senescence and application thereof | |
KR100919134B1 (en) | Extract of antiobestic ginseng with anti-obesity effect comprising high concentration of less polar ginsenoid and method of preparing the same | |
KR102538090B1 (en) | Food composition and health functional food containing Lactobacillus casei IDCC 3451 with proteolytic ability | |
KR102523775B1 (en) | Food composition and health functional food containing Lactobacillus plantarum IDCC 3501 with proteolytic ability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |